Marion McCourt - Feb 7, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/**Marion McCourt
Stock symbol
REGN
Transactions as of
Feb 7, 2023
Transactions value $
-$396,580
Form type
4
Date filed
2/8/2023, 03:14 PM
Previous filing
Feb 3, 2023
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $372K +1K +4.53% $372.46 23.1K Feb 7, 2023 Direct
transaction REGN Common Stock Sale -$769K -1K -4.33% $769.04 22.1K Feb 7, 2023 Direct
holding REGN Common Stock 138 Feb 7, 2023 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1K -13.07% $0.00 6.65K Feb 7, 2023 Common Stock 1K $372.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.